Clinical trial
STILDEP: Zolpidem in Depressive and Dysthimic Patients
NCT00292734 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00292734 |
|---|---|
| Title | STILDEP: Zolpidem in Depressive and Dysthimic Patients |
| Official title | Additive Beneficial Effect of Zolpidem Onto the Antidepressant Therapy in Depressive and Dysthimic Patients in the Acute Phase of the Disease |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders, Depression |
| Intervention type | Drug |
| Interventions | Zolpidem |
| Enrollment | 120 |
| Start date | Jan 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Feb 16, 2006 |
| Last update posted | Dec 6, 2007 |
| Countries | Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: